{"id":413763,"date":"2021-01-13T06:03:32","date_gmt":"2021-01-13T11:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=413763"},"modified":"2021-01-13T06:03:32","modified_gmt":"2021-01-13T11:03:32","slug":"sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/","title":{"rendered":"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance"},"content":{"rendered":"

\nCalls on Analysts and Stockholders Attending J.P. Morgan\u2019s Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q\u201920 Guidance
\n<\/h2>\n
\n

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) — Sian Capital, LLC (together with its affiliates, \u201cSian\u201d or \u201cwe\u201d), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) (\u201cOPKO\u201d or the \u201cCompany\u201d), today announced that it sent a letter to the Company\u2019s Board of Directors (the \u201cBoard\u201d) on December 18, 2020 regarding what we believe is the dubious 4Q\u201920 guidance provided by management on October 29, 2020. Sian wants all analysts and stockholders to be aware that we believe OPKO\u2019s previously issued guidance is misleading. We are calling on OPKO to confirm whether it still stands by its projections or agrees with our estimates.<\/p>\n

Please be advised that OPKO\u2019s management will be hosting one-on-one meetings with investors and presenting at the 39th<\/sup> Annual J.P. Morgan Healthcare Conference on Wednesday, January 13<\/u><\/strong>th<\/u><\/strong><\/sup> at 3:40 p.m. Eastern<\/u><\/strong>. We encourage analysts and investors to review our estimates against OPKO\u2019s guidance and ask management whether it stands by the Company\u2019s 4Q\u201920 guidance. Given that we believe Sian correctly predicted OPKO\u2019s 3Q\u201920 financial results before they were announced, we remain very confident that our current analysis of OPKO\u2019s 4Q\u201920 financials is accurate.<\/p>\n

The below table outlines guidance OPKO provided on its October 29, 2020 conference call compared to the conservative <\/a>guidance estimates<\/a> Sian released on November 12, 2020. Our analysis leads us to believe that OPKO under-guided 4Q\u201920 growth by 26.3%.<\/p>\n\n\n\n\n
\u00a0<\/td>\n\n EBITDA<\/strong>\n <\/td>\n\n Serology Tests <\/strong>\n <\/td>\n\n PCR Tests<\/strong>\n <\/td>\n\n COVID-19 Tests*<\/strong>\n <\/td>\n<\/tr>\n
\n OPKO 4Q\u201920 Guidance<\/strong>\n <\/td>\n$20-30 million<\/td>\n300,000<\/td>\n2.9-3.5 million<\/td>\n3.2-3.8 million<\/td>\n<\/tr>\n
\n Sian’s Estimate<\/strong>\n <\/td>\n$30-40 million<\/td>\n300,000<\/td>\n3.9-4.5 million<\/td>\n4.2-4.8 million<\/td>\n<\/tr>\n<\/table>\n

*OPKO’s “COVID-19 testing guide” includes Serology and PCR Tests.<\/p>\n

The day after OPKO announced its projections, the stock price dropped 20%. In stark contrast, OPKO\u2019s stock price increased 25% in the weeks after we released our 4Q\u201920 estimates on November 12, 2020.<\/p>\n

In our White Paper<\/a> on OPKO\u2019s fundamental value, we refute OPKO\u2019s guidance in detail and provide, in our view, a more accurate guide using public data, the Company\u2019s commentary, public competitors, competitors in the supply chain, government statistics and independent market analysis. We view OPKO\u2019s 4Q\u201920 guidance as unfathomable and urge analysts and investors to ask management today whether the Company:<\/p>\n

    \n
  1. Disagrees with our analysis and stands by its original 4Q\u201920 guidance, or<\/li>\n
  2. Agrees with our analysis and admits its original 4Q\u201920 guidance was incorrect.<\/li>\n<\/ol>\n

    In closing, Sian remains open and willing to engage with OPKO regarding its ideas for high-potential opportunities in the marketplace. Unfortunately, it seems management is no longer interested in engaging with us after ignoring our latest attempts to try to work collaboratively to drive stockholder value. We find it troubling that management would seemingly rather spend investor resources fighting one of its largest stockholders instead of resuming productive discussions with us.<\/p>\n

    For those interested in learning more about the value opportunity at OPKO, visit www.SianCapital.com\/Resources<\/a>. We have provided Sian\u2019s projected 2021 guidance for the Company. Despite recent events, we remain encouraged by the numerous growth prospects for OPKO and its stockholders in 2021.<\/p>\n

    \n About Sian Capital<\/strong>\n <\/p>\n

    Founded by veteran portfolio manager Anish Monga, Sian Capital, LLC is a New York-based asset management firm that employs a focused, event-driven investment approach. Sian\u2019s unique mix of cross-sector experience and activism expertise enables it to identify and invest in what are often overlooked or under-covered investment opportunities.<\/p>\n

    \n Contacts<\/strong>\n <\/p>\n

    Profile
    Greg Marose \/ Charlotte Kiaie
    gmarose@profileadvisors.com<\/a> \/ ckiaie@profileadvisors.com<\/a><\/p>\n<\/p>\n


    \n
    \n \n <\/div>\n

    <\/div>\n","protected":false},"excerpt":{"rendered":"

    Calls on Analysts and Stockholders Attending J.P. Morgan\u2019s Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q\u201920 Guidance NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) — Sian Capital, LLC (together with its affiliates, \u201cSian\u201d or \u201cwe\u201d), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) (\u201cOPKO\u201d or the \u201cCompany\u201d), today announced that it sent a letter to the Company\u2019s Board of Directors (the \u201cBoard\u201d) on December 18, 2020 regarding what we believe is the dubious 4Q\u201920 guidance provided by management on October 29, 2020. Sian wants all analysts and stockholders to be aware that we believe OPKO\u2019s previously issued guidance is misleading. We are calling on OPKO to confirm whether it still stands by its … <\/p>\n

    Continue reading “Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-413763","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Calls on Analysts and Stockholders Attending J.P. Morgan\u2019s Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q\u201920 Guidance NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) — Sian Capital, LLC (together with its affiliates, \u201cSian\u201d or \u201cwe\u201d), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) (\u201cOPKO\u201d or the \u201cCompany\u201d), today announced that it sent a letter to the Company\u2019s Board of Directors (the \u201cBoard\u201d) on December 18, 2020 regarding what we believe is the dubious 4Q\u201920 guidance provided by management on October 29, 2020. Sian wants all analysts and stockholders to be aware that we believe OPKO\u2019s previously issued guidance is misleading. We are calling on OPKO to confirm whether it still stands by its … Continue reading "Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T11:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance\",\"datePublished\":\"2021-01-13T11:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/\"},\"wordCount\":588,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/\",\"name\":\"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==\",\"datePublished\":\"2021-01-13T11:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/","og_locale":"en_US","og_type":"article","og_title":"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance - Market Newsdesk","og_description":"Calls on Analysts and Stockholders Attending J.P. Morgan\u2019s Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q\u201920 Guidance NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) — Sian Capital, LLC (together with its affiliates, \u201cSian\u201d or \u201cwe\u201d), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) (\u201cOPKO\u201d or the \u201cCompany\u201d), today announced that it sent a letter to the Company\u2019s Board of Directors (the \u201cBoard\u201d) on December 18, 2020 regarding what we believe is the dubious 4Q\u201920 guidance provided by management on October 29, 2020. Sian wants all analysts and stockholders to be aware that we believe OPKO\u2019s previously issued guidance is misleading. We are calling on OPKO to confirm whether it still stands by its … Continue reading \"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-13T11:03:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance","datePublished":"2021-01-13T11:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/"},"wordCount":588,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/","name":"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==","datePublished":"2021-01-13T11:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTIwMCMzOTE2OTI3IzUwMDA3NTMxNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sian-capital-urges-opko-health-to-address-apparently-misleading-4q20-guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q\u201920 Guidance"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/413763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=413763"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/413763\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=413763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=413763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=413763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}